Sai Kimie

• 2000 - 抗がん剤応答性の予測法開発と個別化医療への応用
• 2000 - Pharmacogenomic study on anti-cancer drugs

• Takuya Imatoh, Takumi Nishi, Midori Yasui, Toshiki Maeda, Kimie Sai, Yoshiro Saito, Hiroshi Une, Akira Babazono. Association between dipeptidyl peptidase-4 inhibitors and urinary tract infection in elderly patients: A retrospective cohort study. Pharmacoepidemiology and drug safety. 2018. 27. 8. 931-939
• Imatoh T, Sai K, Takeyama M, Hori K, Karayama M, Furuhashi K, Segawa K, Kimura M, Kawakami J, Saito Y. Identification of risk factors and development of detection algorithm for denosumab-induced hypocalcaemia. Journal of clinical pharmacy and therapeutics. 2018. 44. 1. 62-68
• Takuya Imatoh, Kimie Sai, Chisato Fukazawa, Yasushi Hinomura, Ryosuke Nakamura, Yoshimi Okamoto-Uchida, Katsunori Segawa, Yoshiro Saito. Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2017. 73. 12. 1643-1653
• Mayu Takeyama, Kimie Sai, Takuya Imatoh, Katsunori Segawa, Noriyasu Hirasawa, Yoshiro Saito. Influence of Japanese Regulatory Action on Denosumab-Related Hypocalcemia Using Japanese Adverse Drug Event Report Database. BIOLOGICAL & PHARMACEUTICAL BULLETIN. 2017. 40. 9. 1447-1453
• Yoshimi Okamoto-Uchida, Ryosuke Nakamura, Kimie Sai, Takuya Imatoh, Kayoko Matsunaga, Michiko Aihara, Yoshiro Saito. Effect of Infectious Diseases on the Pathogenesis of Stevens Johnson Syndrome and Toxic Epidermal Necrolysis. BIOLOGICAL & PHARMACEUTICAL BULLETIN. 2017. 40. 9. 1576-1580

ｍore...

• Kimie Sai, Yoshiro Saito, Naoko Tatewaki, Masakiyo Hosokawa, Nahoko Kaniwa, Tomoko Nishimaki-Mogami, Mikihiko Naito, Jun-ichi Sawada, Kuniaki Shirao, Tetsuya Hamaguchi, et al. Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2010. 70. 2. 222-233
• Kimie Sai, Yoshiro Saito, Naoko Tatewaki, Masakiyo Hosokawa, Nahoko Kaniwa, Tomoko Nishimaki-Mogami, Mikihiko Naito, Jun-ichi Sawada, Kuniaki Shirao, Tetsuya Hamaguchi, et al. Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2010. 70. 2. 222-233
• Kimie Sai, Yoshiro Saito, Keiko Maekawa, Su-Ryang Kim, Nahoko Kaniwa, Tomoko Nishimaki-Mogami, Jun-ichi Sawada, Kuniaki Shirao, Tetsuya Hamaguchi, Noboru Yamamoto, et al. Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2010. 66. 1. 95-105
• Kimie Sai, Yoshiro Saito, Keiko Maekawa, Su-Ryang Kim, Nahoko Kaniwa, Tomoko Nishimaki-Mogami, Jun-ichi Sawada, Kuniaki Shirao, Tetsuya Hamaguchi, Noboru Yamamoto, et al. Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2010. 66. 1. 95-105
• Kimie Sai, Yoshiro Saito, Hiromi Fukushima-Uesaka, Koichi Kurose, Nahoko Kaniwa, Naoyuki Kamatani, Kuniaki Shirao, Noboru Yamamoto, Tetsuya Hamaguchi, Hideo Kunitoh, et al. Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients. CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2008. 62. 3. 529-537

ｍore...

• Hokkaido University Faculty of Pharmaceutical Sciences
• 北海道大学大学院薬学研究科
• Hokkaido University Faculty of Pharmaceutical Science
• Hokkaido University(Graduate School, Division of Pharmaceutical Sciences )

• Ph.D. (Tohoku University)

• - 現在 日本薬物動態学会 評議員

• 2016/12 - 日本臨床薬理学会学術総会 優秀演題賞 東及び東南アジア地域における薬物動態・薬力学関連ゲノムバイオマーカーの民族差

JAPANESE SOCIETY FOR PHARMACOEPIDEMIOLOGY ,  日本レギュラトリーサイエンス学会 ,  日本臨床薬理学会 ,  日本薬物動態学会 ,  日本薬学会 ,  Japanese Society of Toxicological Sciences ,  Japanese Society of Clinical Pharmacology and Therapeutics ,  Japanese Cancer Association ,  Pharmaceutical Society of Japan